Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 442

1.

Prostate cancer upgrading with serial prostate MRI scans and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?

Osses DF, Drost FH, Verbeek JFM, Luiting HB, van Leenders GJLH, Bangma CH, Krestin GP, Roobol MJ, Schoots IG.

BJU Int. 2020 Mar 31. doi: 10.1111/bju.15065. [Epub ahead of print]

PMID:
32232921
2.

Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment.

Sow HS, Benonisson H, Brouwers C, Linssen MM, Camps M, Breukel C, Claassens J, van Hall T, Ossendorp F, Fransen MF, Verbeek JS.

Sci Rep. 2020 Mar 3;10(1):3933. doi: 10.1038/s41598-020-60893-8.

3.

External validation of novel magnetic resonance imaging-based models for prostate cancer prediction.

Püllen L, Radtke JP, Wiesenfarth M, Roobol MJ, Verbeek JFM, Wetter A, Guberina N, Pandey A, Hüttenbrink C, Tschirdewahn S, Pahernik S, Hadaschik BA, Distler FA.

BJU Int. 2020 Mar;125(3):407-416. doi: 10.1111/bju.14958. Epub 2019 Dec 20.

PMID:
31758738
4.

The Complex Association of FcγRIIb With Autoimmune Susceptibility.

Verbeek JS, Hirose S, Nishimura H.

Front Immunol. 2019 Oct 15;10:2061. doi: 10.3389/fimmu.2019.02061. eCollection 2019. Review.

5.

Systematic Reviews in Occupational Health and Safety: where are we and where should we go?

Verbeek J, Mattioli S, Curti S.

Med Lav. 2019 Oct 29;110(5):331-341. doi: 10.23749/mdl.v110i5.8952.

PMID:
31659990
6.

Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative.

Kalapara AA, Verbeek JFM, Nieboer D, Fahey M, Gnanapragasam V, Van Hemelrijck M, Lee LS, Bangma CH, Steyerberg EW, Harkin T, Helleman J, Roobol MJ, Frydenberg M; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.

Eur Urol Oncol. 2020 Feb;3(1):80-91. doi: 10.1016/j.euo.2019.08.014. Epub 2019 Sep 26.

PMID:
31564531
7.

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling.

Koelink PJ, Bloemendaal FM, Li B, Westera L, Vogels EWM, van Roest M, Gloudemans AK, van 't Wout AB, Korf H, Vermeire S, Te Velde AA, Ponsioen CY, D'Haens GR, Verbeek JS, Geiger TL, Wildenberg ME, van den Brink GR.

Gut. 2019 Sep 10. pii: gutjnl-2019-318264. doi: 10.1136/gutjnl-2019-318264. [Epub ahead of print]

8.

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms.

Verbeek JGE, Atema V, Mewes JC, van Leeuwen M, Oldenburg HSA, van Beurden M, Hunter MS, van Harten WH, Aaronson NK, Retèl VP.

Breast Cancer Res Treat. 2019 Dec;178(3):573-585. doi: 10.1007/s10549-019-05410-w. Epub 2019 Aug 26.

9.

Assessing a Patient's Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood.

Verbeek JFM, Nieboer D, Steyerberg EW, Roobol MJ.

Eur Urol Oncol. 2019 Aug 17. pii: S2588-9311(19)30115-4. doi: 10.1016/j.euo.2019.07.012. [Epub ahead of print]

PMID:
31431394
10.

Validity of criticism of Cochrane Review on closed-system drug-transfer devices.

Gurusamy KS, Ruotsalainen J, Verbeek J, Tanguay C, Best L, Lennan E, Korva M, Bussieres JF.

Am J Health Syst Pharm. 2019 Sep 1;76(17):1267-1269. doi: 10.1093/ajhp/zxz136. No abstract available.

PMID:
31340026
11.

Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Verbeek JH, Rajamaki B, Ijaz S, Tikka C, Ruotsalainen JH, Edmond MB, Sauni R, Kilinc Balci FS.

Cochrane Database Syst Rev. 2019 Jul 1;7:CD011621. doi: 10.1002/14651858.CD011621.pub3.

PMID:
31259389
12.

Wellness: a useful concept but highjacked by commerce.

Verbeek J.

Occup Med (Lond). 2019 Jun 24;69(4):233-234. doi: 10.1093/occmed/kqz060. No abstract available.

PMID:
31232441
13.

Soil-mediated impacts of an invasive thistle inhibit the recruitment of certain native plants.

Verbeek JD, Kotanen PM.

Oecologia. 2019 Jul;190(3):619-628. doi: 10.1007/s00442-019-04435-8. Epub 2019 Jun 13.

PMID:
31197481
14.

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.

Mannaerts CK, Gayet M, Verbeek JF, Engelbrecht MRW, Savci-Heijink CD, Jager GJ, Gielens MPM, van der Linden H, Beerlage HP, de Reijke TM, Wijkstra H, Roobol MJ.

Eur Urol Oncol. 2018 Jun;1(2):109-117. doi: 10.1016/j.euo.2018.02.010. Epub 2018 May 15.

PMID:
31100233
15.

Self-certification versus physician certification of sick leave for reducing sickness absence and associated costs.

Kausto J, Verbeek JH, Ruotsalainen JH, Halonen JI, Virta LJ, Kankaanpää E.

Cochrane Database Syst Rev. 2019 May 14;5:CD013098. doi: 10.1002/14651858.CD013098.pub2.

PMID:
31087323
16.

Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis.

Hirose S, Lin Q, Ohtsuji M, Nishimura H, Verbeek JS.

Int Immunol. 2019 Oct 16;31(11):687-696. doi: 10.1093/intimm/dxz036.

18.

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.

Verbeek JFM, Nieboer D, Parker C, Kattan MW, Steyerberg EW, Roobol MJ.

J Pers Med. 2019 Apr 22;9(2). pii: E19. doi: 10.3390/jpm9020019.

19.

Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.

Verbeek JFM, Roobol MJ.

Urol Oncol. 2019 Jun;37(6):341-342. doi: 10.1016/j.urolonc.2019.02.007. Epub 2019 Mar 8. No abstract available.

PMID:
30857989
20.

Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[3 H]3 methoxy phenyl)-N'-methylguanidine ([3 H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist.

Metaxas A, van Berckel BNM, Klein PJ, Verbeek J, Nash EC, Kooijman EJM, Renjaän VA, Golla SSV, Boellaard R, Christiaans JAM, Windhorst AD, Leysen JE.

Pharmacol Res Perspect. 2019 Feb;7(1):e00458. doi: 10.1002/prp2.458.

21.

Two-Year Follow-Up of a Multi-centre Randomized Controlled Trial to Study Effectiveness of a Hospital-Based Work Support Intervention for Cancer Patients.

Tamminga SJ, Verbeek JHAM, Bos MMEM, Fons G, Kitzen JJEM, Plaisier PW, Frings-Dresen MHW, de Boer AGEM.

J Occup Rehabil. 2019 Dec;29(4):701-710. doi: 10.1007/s10926-019-09831-8.

22.

Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus.

Bánki Z, Werner R, Riepler L, Rössler A, Müllauer B, Hegen V, Bayer W, Verbeek JS, Dittmer U, Stoiber H.

Viruses. 2019 Feb 8;11(2). pii: E145. doi: 10.3390/v11020145.

23.

Assessment of prognosis by physicians involved in work disability evaluation: A qualitative study.

Kox RJ, Hoving JL, Verbeek JH, Schouten MJE, Hulshof CTJ, Wind H, Frings-Dresen MHW.

PLoS One. 2019 Feb 8;14(2):e0212276. doi: 10.1371/journal.pone.0212276. eCollection 2019.

24.

Age, gender, functional KSS, reason for revision and type of bone defect predict functional outcome 5 years after revision total knee arthroplasty: a multivariable prediction model.

Verbeek JFM, Hannink G, Defoort KC, Wymenga AB, Heesterbeek PJC.

Knee Surg Sports Traumatol Arthrosc. 2019 Jul;27(7):2289-2296. doi: 10.1007/s00167-019-05365-x. Epub 2019 Jan 28.

25.

A Dual-Color Bioluminescence Reporter Mouse for Simultaneous in vivo Imaging of T Cell Localization and Function.

Kleinovink JW, Mezzanotte L, Zambito G, Fransen MF, Cruz LJ, Verbeek JS, Chan A, Ossendorp F, Löwik C.

Front Immunol. 2019 Jan 8;9:3097. doi: 10.3389/fimmu.2018.03097. eCollection 2018.

26.

Residual LCMV antigen in transiently CD4+ T cell-depleted mice induces high levels of virus-specific antibodies but only limited B-cell memory.

Schweier O, Aichele U, Marx AF, Straub T, Verbeek JS, Pinschewer DD, Pircher H.

Eur J Immunol. 2019 Apr;49(4):626-637. doi: 10.1002/eji.201847772. Epub 2019 Feb 4.

27.

Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy.

Heerkens M, Dedden S, Scheepers H, Van Paassen P, Masclee A, de Die-Smulders C, Olde Damink SWM, Schaap FG, Jansen P, Koek G, Beuers U, Verbeek J.

Hepatology. 2019 Jun;69(6):2707-2710. doi: 10.1002/hep.30496. Epub 2019 Feb 14. No abstract available.

28.

Crashing NASH in Patients Listed for Bariatric Surgery.

De Munck TJI, Verhaegh PLM, Verbeek J, Verheij J, Greve JW, Jonkers DMAE, Masclee AAM, Koek GH.

Obes Surg. 2019 Mar;29(3):1012-1014. doi: 10.1007/s11695-018-03637-y. No abstract available.

PMID:
30604081
29.

Workplace interventions for reducing sitting at work.

Shrestha N, Kukkonen-Harjula KT, Verbeek JH, Ijaz S, Hermans V, Pedisic Z.

Cochrane Database Syst Rev. 2018 Dec 17;12:CD010912. doi: 10.1002/14651858.CD010912.pub5.

30.

Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.

Verbeek JFM, Bangma CH, Kweldam CF, van der Kwast TH, Kümmerlin IP, van Leenders GJLH, Roobol MJ.

Urol Oncol. 2019 Feb;37(2):138-144. doi: 10.1016/j.urolonc.2018.11.021. Epub 2018 Dec 7.

PMID:
30528698
31.

Incidence of sharps injuries in surgical units, a meta-analysis and meta-regression.

Verbeek J, Basnet P.

Am J Infect Control. 2019 Apr;47(4):448-455. doi: 10.1016/j.ajic.2018.10.003. Epub 2018 Nov 28. Review.

PMID:
30502112
32.

A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADE.

Morgan RL, Thayer KA, Santesso N, Holloway AC, Blain R, Eftim SE, Goldstone AE, Ross P, Ansari M, Akl EA, Filippini T, Hansell A, Meerpohl JJ, Mustafa RA, Verbeek J, Vinceti M, Whaley P, Schünemann HJ; GRADE Working Group.

Environ Int. 2019 Jan;122:168-184. doi: 10.1016/j.envint.2018.11.004. Epub 2018 Nov 22.

33.

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.

Buchan SL, Dou L, Remer M, Booth SG, Dunn SN, Lai C, Semmrich M, Teige I, Mårtensson L, Penfold CA, Chan HTC, Willoughby JE, Mockridge CI, Dahal LN, Cleary KLS, James S, Rogel A, Kannisto P, Jernetz M, Williams EL, Healy E, Verbeek JS, Johnson PWM, Frendéus B, Cragg MS, Glennie MJ, Gray JC, Al-Shamkhani A, Beers SA.

Immunity. 2018 Nov 20;49(5):958-970.e7. doi: 10.1016/j.immuni.2018.09.014. Epub 2018 Nov 13.

34.

High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy.

Benonisson H, Sow HS, Breukel C, Claassens J, Brouwers C, Linssen MM, Fransen MF, Sluijter M, Ossendorp F, van Hall T, Verbeek JS.

J Immunol. 2018 Dec 15;201(12):3741-3749. doi: 10.4049/jimmunol.1800700. Epub 2018 Nov 5.

35.

CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory.

Benonisson H, Altıntaş I, Sluijter M, Verploegen S, Labrijn AF, Schuurhuis DH, Houtkamp MA, Verbeek JS, Schuurman J, van Hall T.

Mol Cancer Ther. 2019 Feb;18(2):312-322. doi: 10.1158/1535-7163.MCT-18-0679. Epub 2018 Oct 31.

36.

Interventions to enhance recovery in healthy workers; a scoping review.

Verbeek J, Ruotsalainen J, Laitinen J, Korkiakangas E, Lusa S, Mänttäri S, Oksanen T.

Occup Med (Lond). 2019 Feb 7;69(1):54-63. doi: 10.1093/occmed/kqy141. Review.

PMID:
30380126
37.

FcγRIIb on B Cells and Myeloid Cells Modulates B Cell Activation and Autoantibody Responses via Different but Synergistic Pathways in Lupus-Prone Yaa Mice.

Lin Q, Ohtsuji M, Amano H, Tsurui H, Tada N, Sato R, Fukuyama H, Nishimura H, Verbeek JS, Hirose S.

J Immunol. 2018 Dec 1;201(11):3199-3210. doi: 10.4049/jimmunol.1701487. Epub 2018 Oct 29.

38.

SHARING AND COLLECTING HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT REPORTS INTERNATIONALLY: IS AN EXTENSIVE PARTICIPATION OF STAKEHOLDERS REALISTIC?

Verbeek J, Hiligsmann M, Cicchetti A, Marchetti M.

Int J Technol Assess Health Care. 2018 Jan;34(5):527-534. doi: 10.1017/S0266462318000570. Epub 2018 Oct 16.

PMID:
30322414
39.

Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression.

Verbeek J, Eriksson J, Syvänen S, Huisman M, Schuit RC, Molthoff CFM, Voskuyl RA, de Lange EC, Lammertsma AA, Windhorst AD.

EJNMMI Radiopharm Chem. 2018 Sep 21;3:11. doi: 10.1186/s41181-018-0046-z. eCollection 2018 Dec.

40.

FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model.

Sow HS, Benonisson H, Breukel C, Visser R, Verhagen OJHM, Bentlage AEH, Brouwers C, Claassens JWC, Linssen MM, Camps M, van Hall T, Ossendorp F, Fransen MF, Vidarsson G, Verbeek JS.

Int J Cancer. 2019 Jan 15;144(2):345-354. doi: 10.1002/ijc.31899. Epub 2018 Nov 12.

41.

Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.

Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW.

Eur Urol. 2018 Dec;74(6):796-804. doi: 10.1016/j.eururo.2018.08.038. Epub 2018 Sep 19. Review.

42.

A Liftless Intervention to Prevent Preterm Birth and Low Birthweight Among Pregnant Ghanaian Women: Protocol of a Stepped-Wedge Cluster Randomized Controlled Trial.

Kwegyir-Afful E, Verbeek J, Aziato L, Seffah JD, Räsänen K.

JMIR Res Protoc. 2018 Aug 23;7(8):e10095. doi: 10.2196/10095.

43.

Work-relatedness of lumbosacral radiculopathy syndrome: Review and dose-response meta-analysis.

Kuijer PPFM, Verbeek JH, Seidler A, Ellegast R, Hulshof CTJ, Frings-Dresen MHW, Van der Molen HF.

Neurology. 2018 Sep 18;91(12):558-564. doi: 10.1212/01.wnl.0000544322.26939.09. Epub 2018 Aug 17.

44.

Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.

Alberts AR, Roobol MJ, Verbeek JFM, Schoots IG, Chiu PK, Osses DF, Tijsterman JD, Beerlage HP, Mannaerts CK, Schimmöller L, Albers P, Arsov C.

Eur Urol. 2019 Feb;75(2):310-318. doi: 10.1016/j.eururo.2018.07.031. Epub 2018 Aug 3.

PMID:
30082150
45.

Could we have better occupational health guidelines, please?

Verbeek J.

Scand J Work Environ Health. 2018 Sep 1;44(5):441-442. doi: 10.5271/sjweh.3764. Epub 2018 Aug 6. No abstract available.

PMID:
30079429
46.

Authors' response: Letter to the Editor concerning OCRA as preferred method in ISO standards on biomechanical risk factors.

Armstrong TJ, Burdorf A, Descatha A, Farioli A, Graf M, Horie S, Marras WS, Potvin JR, Rempel D, Spatari G, Takala EP, Verbeek J, Violante FS.

Scand J Work Environ Health. 2018 Jul 1;44(4):439-440. doi: 10.5271/sjweh.3748.

PMID:
29961082
47.

Workplace interventions for reducing sitting at work.

Shrestha N, Kukkonen-Harjula KT, Verbeek JH, Ijaz S, Hermans V, Pedisic Z.

Cochrane Database Syst Rev. 2018 Jun 20;6:CD010912. doi: 10.1002/14651858.CD010912.pub4. Review. Update in: Cochrane Database Syst Rev. 2018 Dec 17;12:CD010912.

48.

Review and gap analysis: molecular pathways leading to fetal alcohol spectrum disorders.

Ehrhart F, Roozen S, Verbeek J, Koek G, Kok G, van Kranen H, Evelo CT, Curfs LMG.

Mol Psychiatry. 2019 Jan;24(1):10-17. doi: 10.1038/s41380-018-0095-4. Epub 2018 Jun 11. Review.

49.

Fcγ receptor-mediated influx of S100A8/A9-producing neutrophils as inducer of bone erosion during antigen-induced arthritis.

Di Ceglie I, Ascone G, Cremers NAJ, Sloetjes AW, Walgreen B, Vogl T, Roth J, Verbeek JS, van de Loo FAJ, Koenders MI, van der Kraan PM, Blom AB, van den Bosch MHJ, van Lent PLEM.

Arthritis Res Ther. 2018 May 2;20(1):80. doi: 10.1186/s13075-018-1584-1.

50.

Development of the WHO Environmental Noise Guidelines for the European Region: An Introduction.

Jarosińska D, Héroux MÈ, Wilkhu P, Creswick J, Verbeek J, Wothge J, Paunović E.

Int J Environ Res Public Health. 2018 Apr 20;15(4). pii: E813. doi: 10.3390/ijerph15040813.

Supplemental Content

Loading ...
Support Center